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60a Sunday, February 26, 2012conformation in an ATP dependent manner. Chaperonin-mediated protein fold-
ing is achieved on the closure and opening of a built-in lid under ATP cycle.
Recent study with cryo-electron microscopy and single particle analysis sug-
gested that the ring structure of chaperonin twisted to seal off the central cavity.
However such dynamics could not be traced experimentally since the motion
was expected to be too small to detect by visible light technology.
Here we show that ATP dependent dynamic motion of group II chaperonin
from Thermococcus strain KS-1 at single molecular level with high accurate
rotational view by diffracted X-ray tracking (DXT). DXT has been considered
as a powerful technique in biological science for detecting subtle dynamic mo-
tion of the target protein at single molecular level. The dynamics of a single
protein can be monitored through trajectory of the Laue spot from the nanocrys-
tal which was labeled on the objective protein immobilized on the substrate sur-
face. UV-light triggered DXT using caged ATP revealed that the chaperonin’s
lid closed partially within one second after ATP binding, the closed ring twisted
counter clock-wisely from top to bottom view of chaperonin with 130 m rad/sec
in angular speed within 2 to 6 seconds, and the twisted ring turned back to the
original open state with 80 m rad/sec clockwise twisting motion. Our analyses
with precise rotational and macroscopic views for chaperonin’s dynamics show
that there are distinct two modes in lid-closure process, in-cooperative closure
and cooperative counter-clockwise twisting motion. Moreover, we found that
the ring’s twisting motion correlated to the folding activity of group II
chaperonin.
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It is poorly understood how Hsp104, a hexameric AAAþ ATPase from yeast,
disaggregates the diverse structures and unrelated polypeptides that encompass
the stress-induced aggregated proteome, myriad prions, and alpha-synuclein
oligomers and amyloids connected to Parkinson’s disease. Here, we establish
that Hsp104 hexamers adapt fundamentally different mechanisms of intersubu-
nit collaboration (with respect to substrate handling and ATP hydrolysis) to dis-
aggregate stress-induced aggregates versus amyloid. Remarkably, ClpB, the
E. coli homolog of Hsp104, co-ordinates ATP hydrolysis and substrate han-
dling differently and cannot remodel amyloid. Thus, we reveal the operational
plasticity of Hsp104 hexamers, which empowers the disaggregation of amyloid
and non-amyloid clients that impose divergent mechanical demands.
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In Gram-negative bacteria, outer membrane proteins (OMPs) are synthesized in
the cytoplasm. The translocation of OMPs across the periplasm in unfolded
state is assisted by periplasmic molecular chaperones. The Seventeen-Kilo-
Dalton protein, Skp, is a homotrimeric periplasmic chaperone known to facil-
itate folding and insertion of various OMPs into the membrane. To gain
a better insight into the mechanism, by which Skp binds its client proteins in
the periplasm, we designed, expressed and isolated a new Skp construct,
Scp, from E. coli. in this construct, the three Skp monomers were linked
together with two short and flexible linkers. The function of Scp was confirmed
by comparison with wild-type Skp in membrane protein folding experiments
with OmpA.
To examine the topology of Scp$OmpA complexes, we have used site directed
mutagenesis and fluorescence spectroscopy. Our first aim was to identify bind-
ing regions in the Scp chaperone at the level of individual amino acid residues.
Nine single-cysteine Scp mutants were constructed. The cysteine residues in
these mutants were spectroscopically labeled with the fluorescent probe IAE-
DANS. Fluorescence resonance energy transfer (FRET) was then used to probe
the interaction between the Scp mutants and a set of single-tryptophan mutants
of OmpA.
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University, Columbus, OH, USA.The feline immunodeficiency virus (FIV) nucleocapsid (NC) protein contains
66 amino acids. It has similar composition to HIV-1 NC, with a high number
of positively charged amino acids and two zinc fingers, each having a single
aromatic residue (F12 and W44). However, there are some differences between
the structures of these two proteins, which likely contribute to their different
nucleic acid chaperone properties. In addition to a short N-terminal basic
domain, FIV NC has a C-terminal positively charged tail. Moreover, whereas
HIV-1 NC’s two aromatic residues are located on the same side of each zinc
finger domain, FIV NC’s aromatic residues are located on opposite sides of
the zinc fingers. It is known that HIV-1 NC has optimal chaperone activity, in-
cluding the ability to strongly aggregate nucleic acids, destabilize nucleic acid
secondary structure and facilitate rapid protein-nucleic acid interaction kinet-
ics. We use single molecule experiments to measure the characteristics of
wild type and mutant FIV NC. By stretching single DNAmolecules in the pres-
ence of these proteins, we measure their ability to induce aggregation, stabilize
or destabilize dsDNA, and facilitate nucleic acid annealing. Our results show
that wild type FIV NC induces significant DNA aggregation, but instead of
destabilizing double-stranded DNA, it appears to stabilize the DNA. FIV NC
variants containing mutations in the aromatic residues, basic residues, and
zinc finger residues possess strongly altered nucleic acid chaperone properties.
This work allows us to directly relate FIV NC structure with its function.
The single molecule experiments are also compared to ensemble nucleic acid
binding and chaperone studies. Taken together, this study sheds new light on
the mechanism by which specific types and locations of residues contribute
to NC’s nucleic acid chaperone activity and retroviral replication in these
systems.
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Alpha Crystallin is the major protein component of the human lens and plays
an important role in the prevention of cataracts. a-Crystallin (aX) oligomers
consist of two isoforms, aX-A and aX-B which share high sequence similarity
and define the common a-Crystallin fold found in many small heat shock pro-
teins (sHSPs). aX-A and aX-B are hypothesized to play two important roles
within the lens. First, aX-A and aX-B belong to a group of proteins called
Crystallins (a, b, and g) that are very stable proteins that play a role in pre-
serving a uniform density within the lens, which allows it to focus light.
The Crystallin proteins’ ability to form diverse and stable oligomers results
in a glass-like rather than crystalline organization to the lens protein material,
which also aids in the long-term stability of this high-density protein organ.
Second, aX-A and aX-B both function as sHSPs that bind to misfolded pro-
teins, preventing formation of large, insoluble protein aggregates (the begin-
ning of cataracts). Our lab is investigating the molecular interactions
between aX-A and aX-B that result in its stability, diverse oligomerization,
and chaperone function. To this end we are using a model, inducible misfold-
ing protein (insulin B-chain) to study chaperone function by light scatter under
various conditions. We are also using random and targeted modification of
aX-A and aX-B to simulate long-term protein damage and degradation ob-
served in aged lenses. Focus on the C-terminal strand exchange observed in
recent crystal structures and proposed to aid in aX-A and aX-B polydisperse
oligomerization is additionally aiding experimental design. We hope to iden-
tify specific molecular interactions that result in aX-A and aX-B’s chaperone
function, and determine how those interactions relate to stability and self-
oligomerization.Protein-Ligand Interactions I
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This study aims to carry out a molecular docking process of novel inhibitors for
Protein kinase B-beta (PKBb / AKT-2), activation of which has been observed
in 30-40% of ovarian and pancreatic cancers. In this project, it is aimed to find
novel potential ATP competitive inhibitors. 3D pharmacophore filtering by
Phase and multistep docking and scoring by Glide are applied to two crystal
structures of Akt-2 to take into account the conformational change upon the
binding of different inhibitors. The molecular library CoCoCo is screened to
find hits. This procedure combines the pharmacophore perception and database
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using two different protein conformations and also takes into account the sol-
vation effect by including conserved water molecules in the active site. The top
ranked molecules from each pharmacophore hypothesis are further analyzed
according to their interactions with AKT-2 and the ultimate docking results
from Glide are compared with previously identified inhibitors based on struc-
ture and chemistry.
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Glioblastoma multiforme (GBM) is a very aggressive brain cancer in humans.
Even with improvements in surgical, radiation, and chemotherapy treatments,
current prognosis is bleak, with only a 14-month median survival time. LYN,
an important kinase involved in cell regulation, is often overexpressed in
GBM. This work addresses computational design of druglike small molecules
that could potentially inhibit LYN and thus hinder GBM progression. New pu-
tative LYN inhibitors were obtained by atomic substitutions and structural
alterations of bafetinib, a small molecule previously found to bind LYN. Drug-
like properties and toxicities of the designed molecules were evaluated using
the Osiris Property Explorer program. Molecules with no implied toxicities
and most favorable druglike properties were used for docking studies in the
ArgusLab program. Designed molecules that made the most stable docking
configurations with LYN, but no stable configurations with other kinases,
were identified as LYN-specific. Binding energies of the stable complexes
formed by these molecules and LYN were calculated. Possible utilization of
the designed molecules in drug research against GBM is discussed.
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As part of our effort to understand the determinants of drug binding to the Abl
tyrosine kinase, we determined the crystal structure of the Abl kinase domain
bound to a derivative of the PP1 nucleoside analog. Just as the cancer drug im-
atinib selectively inhibits the tyrosine kinase activity of c-Abl, c-Kit, and the
PDGF receptor, but is a poor inhibitor of the closely related Src kinases (1),
PP1 is a selective inhibitor of the Src family (2), c-Kit (3), and PDGFR kinases
but not of Abl tyrosine kinase activity (3, 4). In fact, PP1 is 1000X less effective
at inhibiting Abl and Bcr-Abl kinases than at inhibiting the Src kinases (3, 4).
We rationally designed a derivative of the PP1 compound to introduce hydro-
gen bonding between it and a strictly conserved lysine residue that coordinates
the alpha and beta phosphate groups of ATP in protein kinases (5). By expand-
ing the interactions between the inhibitor and Abl kinase, we sought to make
the PP1 derivative, AB129, less selective. Our crystal structure of the Abl ki-
nase domain bound to the AB129 inhibitor shows three important features.
First, the compound binds to the kinase domain in the active conformation: al-
pha C helix is rotated inward facilitating a salt bridge between Lys271 and
Glu286 and the conserved Asp-Phe-Gly (DFG) motif is oriented Asp-In. In
contrast, the structure of PP1 bound to the Src family kinase Hck is in the in-
active conformation (6). Second, the strictly conserved Glu286 residue, not
Lys271, hydrogen bonds to the hydroxyl group of AB129. Third, the conforma-
tion of the phosphate binding loop (P-loop) is extended. We provide kinetic and
calorimetric data to support our rationale for the observed conformational
changes.
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The uncontrolled kinase activity of the oncogenic protein Bcr-Abl is a hall-
mark of Chronic myelogenous leukemia (CML). Although the drug imtanib
is highly effective at shutting down aberrant Abl kinase activity, some
CML patients harbor additional mutations in their bcr-abl gene that renders
their gene product, the Bcr-Abl protein, resistant to this drug. Since secondgeneration Abl kinase inhibitors such as dasatinib are effective only against
particular resistant mutant proteins, new targeted agents are needed to combat
drug resistance. Two combi-inhibitors ZRF1 and ZRF2, which block Bcr-Abl
activity and damage DNA in the cell, have been shown to be more potent than
imatinib in cellular assays. Since both ZRF1 is hydrolyzed in the cell to ZRF0,
an imatinib analog in which only the mono-substituted benzamide piperazinyl
moiety is replaced with bi-substituted amino and trifluoromethyl groups, we
wondered why these two changes had such a profound effect on the potency
of the drug. To determine whether ZRF1/2’s increased potency was due to the
DNA damaging agent attached to the parent compounds, we sought to co-
crystallize the Abl kinase domain with these two inhibitors at room tempera-
ture and 4C using commercially available sparse-matrix screens. We
screened over 400 crystallization conditions, with Abl and ZRF1, ZRF2, or
dasatinib inhibitors but were unable to obtain crystals of either the Abl-
ZRF1 or Abl-ZRF2 drug complex. Protein crystals in wells containing the
Abl kinase domain and dasatinib, however, were evident in every tray. Since
ZRF1 and ZRF2 are hydrolyzed in the cell, future co-crystallization studies of
Abl and its mutant proteins will employ the hydrolyzed inhibitor analogs as
the ligand.
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The large and growing body of experimental data on biomolecular binding is of
enormous value in developing a deeper understanding of molecular biology, in
developing new therapeutics, and in various molecular design applications.
However, most of these data are found only in the published literature and
are therefore difficult to access and use. BindingDB is a public web-
accessible database of measured binding affinities for various molecular types.
The BindingDB allows queries based upon a range of criteria, including chem-
ical similarity or substructure, sequence homology, numerical criteria and reac-
tant names. The data specification includes significant experimental detail. The
time and expense required to extracting data from the literature, for this and
many other databases, highlight the importance of moving toward machine-
readable components of publications.
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Protein-ligand docking techniques are one of the essential tools for structure-
based drug design. Although conformational changes of protein receptor fre-
quently occur in the binding process, a large fraction of contemporary docking
programs ignore receptor flexibility. Consideration of protein flexibility effi-
ciently and accurately in docking studies is challenging due to difficulties in
finding accurate scoring function and in sampling conformations efficiently.
Previously we developed a docking program called LigDockCSA which incor-
porates LigDock scoring function that combines AutoDock3 and PLP scoring
function and conformational space annealing (CSA) as a sampling method.
However, the program treats protein rigid. Here, we present GALAXYDock,
an extension of LigDockCSA that accounts flexibility of pre-selected side-
chains of receptor protein in the binding site. To test the performance of the
new docking method, 3 sets of protein-ligand complexes that share similar
backbone structures but have different side chain conformations were selected
as test sets: HIV-PR, LXRb and cAPK. The cross-docking results show that the
accuracy of binding pose prediction is increased about 20% when compared
with our previous rigid-receptor results.
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The study of the binding and effects of polyaromatic hydrocarbons (PAH) to
proteins remains one of the fundamental aspects of research in biophysics.
Among other processes, ligand binding can regulate the function of proteins in-
cluding inhibiting their action. Binding to small ligands remains a very im-
portant aspect in the study of the function of many proteins. We studied
a new class of 3,9-substituted perylene derivatives designed to optimize
